A drug that simultaneously strikes cancer cells’ growth circuits and pipeline to the bloodstream produced encouraging results in a clinical trial involving patients with advanced neuroendocrine tumors, according to a study led by Dana-Farber Cancer Institute investigators.
Hospital CEO’s ‘Naked Art’ Suit; Family Sues Over Dead Baby Images; Lost Tumor Suit
The former CEO of a large New Jersey health system is suing his former employer, claiming he was wrongfully terminated over a “naked art” exhibition